Introduction Semaglutide has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://daltonxadfh.wikibriefing.com/2999763/semaglutide_a_breakthrough_in_metabolic_health_and_wellness